Cervical cancer is the fourth most common malignancy in women of reproductive age
globally. The burden of this disease is highest in low-income and middle-income countries …

To support a strategy to eliminate cervical cancer as a public health problem, the World
Health Organisation (WHO) reviewed its guidelines for screening and treatment of cervical …

HIV substantially worsens human papillomavirus (HPV) carcinogenicity and contributes to
an important population excess of cervical cancer, particularly in sub‐Saharan Africa (SSA) …

An estimated 38 million people live with human immunodeficiency virus (HIV) worldwide
and are at excess risk for multiple cancer types. Elevated cancer risks in people living with …

Introduction Women living with HIV experience heightened risk of cervical cancer, and over
50% of cases in Southern Africa are attributed to HIV co-infection. Cervical cancer …

Objectives Mathematical modeling is increasingly used to inform cervical cancer control
policies, and model-based evaluations of such policies in women living with human …

Background Cervical cancer screening uptake remains low despite being a critical
prevention method for adult women living with HIV (WLHIV). These women experience …

Objective Exploring the predictive value of NLR, PLR, MLR, and SII for the severity of
cervical cancer screening abnormalities in patients. Methods A retrospective analysis was …

The WHO strategy for the elimination of cervical cancer sets 2030 targets for the scale-up of
HPV vaccination, cervical screening, and pre-cancer and invasive cancer treatment …

Human immunodeficiency virus (HIV) control is one of the most heavily studied diseases of
our time, as an estimated 32.7 million people have lost their lives to HIV-related illnesses …